Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers
Daniel Roche(University of Maryland, Baltimore), Lara A. Ray(University of California, Los Angeles), Emily E. Hartwell(University of California, Los Angeles), ReJoyce Green(Medical University of South Carolina), Spencer Bujarski(University of California, Los Angeles)
Cited by 20
Related Papers
State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
|The American Journal of Drug and Alcohol Abuse|2018|137
Effects of varenicline on subjective craving and relative reinforcing value of cigarettes
|Drug and Alcohol Dependence|2018|64
Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis
|Addiction Biology|2019|60
Predictors of Substance Use Initiation by Early Adolescence
|American Journal of Psychiatry|2024|60
Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial
|American Journal of Psychiatry|2021|37